InsiderTrades

Form 4 for DNA Ginkgo Bioworks Holdings, Inc.

Accepted 2025-08-26 00:00:00 ET · period of report 2025-08-21 · accession 0001977441-25-000006 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2025-08-26 2025-08-21 DNA Coen Steven P. See remarks M - OptEx — +743 11.4K +7% —
D 2025-08-26 2025-08-22 DNA Coen Steven P. See remarks S - Sale+OE $12.40 -310 11.1K -3% -$3,844
DM 2025-08-26 2025-08-21 DNA Coen Steven P. See remarks M - OptEx — -743 12.3K -6% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-08-21 M A 587 — 11,266 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
2 Common Class A Common Stock 2025-08-22 S D 310 $12.40 11,112 D — —
3 Common Class A Common Stock 2025-08-21 M A 156 — 11,422 D — — (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
4 Derivative Restricted Stock Units 2025-08-21 M D 156 — 4,847 D — · — to — 156 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F4) The RSUs vest as follows: 2/48ths of the underlying shares vested on May 1, 2024, then 46 equal monthly installments thereafter.
5 Derivative Restricted Stock Units 2025-08-21 M D 587 — 12,340 D — · — to — 587 Class A Common Stock (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F3) The RSUs vest as follows: 25% of the underlying shares vested on May 1, 2024, then 36 equal monthly installments thereafter.